Zelira Therapeutics Limited (FRA:G1G)
Germany
· Delayed Price · Currency is EUR 0.1740
+0.0030 (1.75%)
At close: Dec 4, 2025
Zelira Therapeutics Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2016 - 2020 |
| Net Income | -3.63 | -36.57 | -5.57 | -11.95 | -8.55 | Upgrade
|
| Depreciation & Amortization | 0.27 | 0.48 | 0.55 | 0.59 | 0.47 | Upgrade
|
| Asset Writedown & Restructuring Costs | -1.15 | 29.83 | -1.14 | -1.29 | -1.38 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | 0.07 | 0.18 | Upgrade
|
| Stock-Based Compensation | -1.19 | 0.04 | 0.4 | 2.69 | 1.3 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | -1.46 | 1.51 | - | Upgrade
|
| Other Operating Activities | -0.2 | 0.11 | -0.89 | -0.36 | -0.08 | Upgrade
|
| Change in Accounts Receivable | 0.18 | -0.21 | 0.28 | -0.12 | -0.12 | Upgrade
|
| Change in Inventory | 0.77 | 0.28 | 0.36 | -1.09 | -0.87 | Upgrade
|
| Change in Accounts Payable | 0.04 | 1.67 | 0.23 | 0.53 | 0.43 | Upgrade
|
| Operating Cash Flow | -4.91 | -4.39 | -7.25 | -9.43 | -8.62 | Upgrade
|
| Investment in Securities | - | - | 0.74 | - | - | Upgrade
|
| Other Investing Activities | 1.15 | 0.92 | 2.09 | -0.21 | 1.38 | Upgrade
|
| Investing Cash Flow | 1.15 | 0.92 | 2.83 | -0.21 | 1.38 | Upgrade
|
| Short-Term Debt Issued | 1.09 | 3.92 | - | - | - | Upgrade
|
| Long-Term Debt Issued | 2.1 | - | - | - | - | Upgrade
|
| Total Debt Issued | 3.19 | 3.92 | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | 3.19 | 3.92 | - | - | - | Upgrade
|
| Issuance of Common Stock | - | - | 1.77 | 7.1 | 10.62 | Upgrade
|
| Other Financing Activities | -0 | - | - | - | -0.09 | Upgrade
|
| Financing Cash Flow | 3.19 | 3.92 | 1.77 | 7.1 | 10.53 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.02 | -0.02 | 0.05 | 0.31 | -0.02 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | - | -0 | Upgrade
|
| Net Cash Flow | -0.58 | 0.44 | -2.6 | -2.22 | 3.27 | Upgrade
|
| Free Cash Flow | -4.91 | -4.39 | -7.25 | -9.43 | -8.62 | Upgrade
|
| Free Cash Flow Margin | -747996.04% | -4621.90% | -2407.36% | -611.91% | -1299.02% | Upgrade
|
| Free Cash Flow Per Share | -0.43 | -0.39 | -0.72 | -1.17 | -1.30 | Upgrade
|
| Cash Interest Paid | 0.33 | 0.04 | 0.03 | - | - | Upgrade
|
| Levered Free Cash Flow | -0.76 | -4.02 | -2.64 | -5.69 | -4.72 | Upgrade
|
| Unlevered Free Cash Flow | -0.51 | -3.55 | -2.59 | -5.66 | -4.69 | Upgrade
|
| Change in Working Capital | 0.99 | 1.73 | 0.86 | -0.69 | -0.56 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.